In
Insitro
S San Francisco CAFounded 2018200 employees
Private CapbiotechPrivateNeurologyHepatology
Platform: ML Drug Disco
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Mavurapivir | INS-9567 | Phase 1 | 2 | GLP-1R | FTDSLE | ||
| INS-9902 | INS-9902 | Phase 1/2 | 2 | JAK2 | AsthmaHuntington's | ||
| INS-3736 | INS-3736 | Phase 1 | 2 | CGRP | Crohn's |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)